Best Work Places

UMMS and iHarbor Named 2025 Modern Healthcare Innovators Award Recipients

The University of Maryland Medical System (UMMS) and its iHarbor Innovation Center have been named as one of the distinguished recipients of Modern Healthcare’s 2025 Innovators Awards, celebrating both outstanding individuals and organizations leading health care innovation. The honor recognizes iHarbor for its development of Gallion, a cloud-based, digital supply chain application that redefines the management of bill-only transactions by digitizing and standardizing workflows, enhancing accuracy, compliance, and efficiency. “Discovery is one of our System’s values. We pride ourselves on innovation and being on the forefront of transformative change in health care,” said Mohan Suntha, MD, MBA, the System’s President and Chief Executive Officer. “We are honored that Modern Healthcare has recognized Gallion’s impact in reducing costs and improving patient care.” Gallion seamlessly integrates with electronic health record (EHR) and enterprise resource planning (ERP) systems, automating critical tasks such as consumption tracking, charges and contract compliance. Before Gallion's implementation in 2021 automated these processes, UMMS relied on a manual labor-intensive paper-based process that had the potential for errors and inefficiencies. Data from the deployment of Gallion across UMMS' 11 hospitals shows significant operational improvements; completion time has been reduced by 75% and the defect/error rate has lowered from 18% to just 3%. Modern Healthcare’s Innovators program recognizes leaders and organizations driving innovation that improves care, achieves measurable results and contributes to the clinical and financial goals of the organization. “Artificial intelligence, the use of data and technology investments are transforming healthcare — streamlining workflows, improving patient care and creating new business opportunities,” said Mary Ellen Podmolik, editor-in-chief of Modern Healthcare. “The ambitious work underway by our 2025 Innovators Awards’ honorees is producing exciting results that will lead to better results for patients and these organizations that are tackling the industry’s biggest challenges.” iHarbor, a wholly-owned subsidiary of UMMS, is now bringing Gallion to the market, enabling other hospitals and health systems to realize similar benefits. The enterprise platform offers robust analytics, giving supply chain teams unparalleled insight into cost management, contract competitiveness and compliance, and clinical quality outcomes. “Gallion streamlines processes in supply chain and for surgical procedures and empowers health systems with an innovative and integrated solution,” said Warren D’Souza, PhD, MBA, UMMS’ Senior Vice President and Chief Innovation Officer. “Better management of high cost supplies allows for optimized spend management and ultimately a better experience for the health care team and patients.” “Through projects like Gallion, the iHarbor Innovation Center is helping to transform health care delivery across our System and beyond,” said Guy Henggeler, Vice President, iHarbor Strategy and Operations.

Biopharm Wins 'Excellence in Generic Medicine Development, Algeria, 2024' at Global Brand Awards

Biopharm, a leading pharmaceutical company in Algeria, has been awarded the prestigious title of 'Excellence in Generic Medicine Development, Algeria, 2024' by Global Brands Magazine (GBM) at the renowned Global Brand Awards. This distinguished recognition underscores Biopharm's exceptional dedication to pioneering innovation and advancing public health through high-quality generic medicines. The Global Brand Awards celebrate the highest achievements across industries worldwide. Biopharm received this award for its dedication to healthcare innovation and excellence in developing generic medicines. Jay Reddy, CEO of Global Brands Magazine, commented, "We are pleased to honour Biopharm with the Excellence in Generic Medicine Development award in Algeria. This accolade is a testament to their unwavering commitment to innovation, quality, and accessibility in the pharmaceutical industry. It's an honour to celebrate their dedication to improving lives through ground breaking solutions." "By placing the patient at the heart of our research and activities, Biopharm continues to develop accessible and effective therapeutic solutions, while adopting sustainable and responsible practices. Thereby, this award illustrates perfectly our ability to combine operational excellence, scientific commitment, and the desire to improve the health of patients. Developing quality medicines accessible to as many people as possible is at the core of our mission," said Abdelhalim BENMERAD,CEO, Biopharm.

Singapore’s Best Workplaces in Healthcare & Biopharma 2025 Announced

Great Place To Work®, the global authority on workplace culture, has officially announced Singapore's Best Workplaces in Healthcare & Biopharma™ 2025 list, celebrating 10 pioneering healthcare and biopharma companies that have created exceptional workplace cultures. Now in its third year since the list's inaugural launch, this recognition highlights organizations setting new benchmarks in employee experience, trust, and workplace excellence in the healthcare sector. This year, Medtronic, a global leader in medical technology, services, and solutions, is among the new entrants on the list. Medtronic has also ranked among the Top 10 companies on the Singapore Best Workplaces™ list for three consecutive years, reinforcing its commitment to a strong workplace culture and employee engagement. Another notable new entrant is MSD International GmbH (Singapore Branch), a premier research-intensive biopharmaceutical company that has been inventing medicines and vaccines for over 130 years, making a significant impact on global healthcare. This year's Best Workplaces™ list was determined through confidential employee feedback, representing the voices of nearly 10,000 employees across Singapore's Healthcare & Biopharma industry. Employee responses to over 60 survey questions were evaluated to assess the extent to which these organizations create a Great Place To Work For All™. The companies featured on this list automatically qualify for the Singapore Best Workplaces™ 2025 list and vice versa. "The biopharmaceutical industry has experienced rapid growth in recent years, driven by advancements in medical technology, increased investment in R&D, and the demand for innovative healthcare solutions. This evolving landscape has significantly influenced employee development, fostering a workforce that thrives in cutting-edge research, digital transformation, and patient-centered care. Being recognized as one of Singapore's Best Workplaces in Healthcare & Biopharma™ underscores the commitment of these organizations to not only advance the industry but also cultivate a work environment that empowers employees to grow, innovate, and contribute to meaningful healthcare advancements," said Evelyn Kwek, Managing Director, Great Place To Work® ASEAN & ANZ.

BD Named One of America's Most Innovative Companies by Fortune

BD, a leading global medical technology company, was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products, streamlining processes, and cultivating a forward-thinking corporate culture. "As one of the largest manufacturers of medical devices in the world whose products touch billions of patients around the globe, building on our long history of innovation is a responsibility we take very seriously," said Tom Polen, chairman, CEO and president of BD. "Through the ingenuity of our world-class team who strives to address unmet needs in healthcare every day, coupled with BD Excellence - our culture of continuous improvement - we can live our purpose and manufacture innovative medical products at scale as we deliver for our customers and the patients we serve." Fortune and Statista surveyed more than 40,000 U.S. employees and more than 2,500 industry experts to rank companies across the following three categories: Product innovation: Regular introduction of new products or services and improvement of existing products and services, in addition to the number and relevance of industrial property rights in the form of patents. Process innovation: Development and use of new and innovative technologies and production processes, as well as the innovative use of digitalization and the resulting opportunities. Innovation culture: Extent a company fosters a spirit of entrepreneurship and creativity, encouraging their employees to take initiative and develop new ideas.

Novotech Named Best Contract Research Organization in Australia

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market, has been recognized as the Best Contract Research Organization in Australia at the Asia-Pacific Biopharma Excellence Awards (ABEA) 2025 The Asia-Pacific Biopharma Excellence Awards 2025, which celebrates excellence in clinical trials among others, recognizes organizations, experts, and technologies at the forefront of biopharma innovation. Winners are selected through 100% industry voting, ensuring recognition by industry peers. At the recent Awards event held at the Sands Expo & Convention Center in Singapore, Chris Chong, Senior Director of Clinical Services, accepted the award on behalf of Novotech. In his remarks, Mr. Chong expressed gratitude for the recognition, stating, “We thank the Asia-Pacific Biopharma Excellence Awards for this recognition. This award reflects the dedication of our teams worldwide who support biopharma innovation. Our clients and partners entrust us with their research, and we take pride in accelerating the development of new therapies. Novotech remains committed to advancing clinical research, strengthening partnerships, and maintaining high standards in biopharma development.” This recognition further strengthens Novotech’s industry leadership, adding to its long-standing achievements, including being named Frost & Sullivan CRO Company of the Year award for 19 consecutive years .

Rx relief Honored as a Best Staffing Firm for Women

Rx relief, a pharmacy staffing division of The PrideStaff Companies, announced that it has been named to ClearlyRated's list of Best Staffing Firms for Women. This is the first year Rx relief has received this recognition, signifying their dedication to creating an outstanding experience for female employees. Fewer than .1% of staffing firms qualify for this elite designation, which is based on stringent criteria that include the following: A firm must invite feedback from 100% of its internal staff on their overall experience within their organization. Women must comprise at least 47% of the workforce, rate the firm highly, and be highly represented in leadership roles. This year, Rx relief also earned its second consecutive Best of Staffing® Client and Talent 15-Year Diamond Awards from ClearlyRated for providing superior service to clients and candidates, as well as ClearlyRated's Best of Staffing® Employee 5-Year Diamond Award for providing an exceptional employee experience. "At Rx relief, we take deep pride in how our workplace values, supports, and empowers each team member to succeed," said Mike April, Co-CEO of PrideStaff. "Being named to ClearlyRated's Best Staffing Firms for Women list is a powerful testament to the culture we're building every day. One that champions collaboration and professional growth at every level." Aprile continued, "What makes this recognition truly meaningful is that it comes directly from the voices of our employees. Their feedback affirms that Rx relief is not just a great place to work, but a special organization where individuals can thrive, contribute, and advance their careers. We're grateful for our incredible team and remain committed to fostering an environment where everyone has the opportunity to excel." "I'm excited to unveil the companies recognized on the third annual Best Staffing Firms for Women list," stated Baker Nanduru, CEO of ClearlyRated. "As we continue to celebrate Women's History Month, these exceptional firms deserve applause for championing and empowering their female employees. Despite persistent challenges like pay disparity and limited advancement opportunities, these firms are at the forefront of fostering growth and elevating women in the workforce. Congratulations and heartfelt thanks to these outstanding organizations for their unwavering commitment to gender diversity and equality."

WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025

WuXi XDC Cayman Inc. a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with four prestigious awards at the Asia-Pacific Biopharma Excellence Awards 2025. The Asia-Pacific Biopharma Excellence Awards honor companies annually that have exhibited outstanding performance and achievement in the biopharmaceutical sector. These accolades underscore WuXi XDC's leadership, innovation, and fully integrated CRDMO platform, empowering global clients from early discovery to commercial manufacturing. Industry-leading development and manufacturing capabilities (Best ADC CDMO in Asia & China): WuXi XDC's state-of-the-art facilities and global dual-sourcing strategy enable seamless CMC development and GMP manufacturing, accelerating the timeline while ensuring a high success rate and regulatory excellence. Innovation in Discovery & Development (Best ADC CRO in Asia): WuXi XDC's proprietary conjugation and payload-linker technologies, along with the incorporation of external technologies through partnerships, drive ADC and XDC discovery, optimization, and IND-enabling studies, expediting clients' clinical advancement. Pioneering ADC Technology (Best ADC Platform Technology): Through next-generation payload-linker innovations and site-specific conjugation technologies, from internal development and external partnership, WuXi XDC provides clients with diversified technology suites to advance ADC and XDC developments. Dr. Jimmy Li, CEO of WuXi XDC, commented: "We are honored to receive these prestigious awards, which not only reaffirm our team's relentless pursuit of excellence and innovation in the ADC field but also underscore our dedication to delivering world-class services that empower our clients to bring novel therapies to patients worldwide. They are a testament to the hard work and dedication of every WuXi XDC employee – their relentless efforts that have made this milestone possible. It also belongs to our valued partners, whose trust and collaboration have driven our collective success. Looking ahead, WuXi XDC will continue to support our clients and advance the innovation and progress of the global bioconjugate industry." These awards follow WuXi XDC's recent recognition at the 2024 World ADC Awards, where the company was named Best CDMO Winner for the second consecutive year, further solidifying its leadership position in the global ADC industry. As the ADC market continues to experience sustainable growth, WuXi XDC relentlessly committed to advancing its technological capabilities and expanding its service offerings to meet clients' evolving needs.

Exact Sciences Wins 2025 Gallup Exceptional Workplace Award

Exact Sciences Corp, announced it has received the 2025 Gallup Exceptional Workplace Award (GEWA), marking the second year in a row the company has received this prestigious recognition. This award recognizes the most engaged workplace cultures in the world. Gallup created the Exceptional Workplace Award to identify excellence and celebrate organizations that incorporate employee engagement into the bedrock of how they do their work, motivate their teams, and achieve business outcomes. "Exact Sciences’ success starts with our people, and winning the Gallup Exceptional Workplace Award for the second consecutive year is a testament to the dedication of our incredible team," said Sarah Condella, executive vice president of human resources at Exact Sciences. "Our culture is built on shared values, collaboration, and a relentless commitment to our mission. By fostering an environment where employees feel engaged, supported, and empowered, we continue to make a meaningful impact on patients and advance our fight against cancer." “Congratulations to this year’s Gallup Exceptional Workplace Award winners for setting the standard for a thriving workplace. Your commitment to creating an environment where employees feel valued, heard and empowered to do their best work is truly remarkable. By prioritizing both people and performance, you are shaping the future of work and proving that exceptional workplaces drive real results,” said Jon Clifton, Gallup’s chief executive officer. Gallup’s meta-analysis on team engagement and performance is the most comprehensive workplace study ever conducted, with data on more than 3.3 million employees in 347 organizations across 53 industries and 90 countries. The company’s research shows that highly engaged organizations significantly outperform their peers in important business outcomes, including customer ratings, profitability, productivity, turnover, safety incidents, shrinkage, absenteeism, quality, well-being, and organizational citizenship. Exact Sciences is looking for talented people who are passionate about helping patients and fighting cancer

Advantum Health Recognized as one of Kentucky's Best Places to Work for Second Consecutive Year

Advantum Health, an industry-leading practice revenue management authority based in Louisville, has been recognized by The Kentucky Chamber of Commerce and the Kentucky Society for Human Resource Management (KYSHRM) as one of 2025's Best Places to Work in Kentucky. Tammy Taylor, CEO of Advantum Health, shared her excitement, "Our culture at Advantum Health attracts talent to the company and helps retain good team members over time. We have fostered an inclusive and open culture that allows employees to express themselves and be heard. Our clients reap the benefits of this dedicated, talented and high-performing workforce. And consistent communication has worked wonders in keeping our team members engaged." Managed by Workforce Research Group, the selection process is based on the results of an internal employee survey as well as a thorough assessment of the company's benefits, perks, employee policies and procedures. Advantum is dedicated to employee support and engagement through programs such as: Town hall meetings to give "state of the company" addresses, Multiple mentorship groups at different levels of the company, Go Green Committee to advance sustainability and volunteerism, Dedicated training and education team, Veterans support group, Buddy program to pair new employees with existing team members. Chief Administrative Officer, Samantha Wagner, discussed Advantum's unique culture, saying, "In a partially remote and global work environment, technology and team building are necessary to facilitate authentic relationships and healthy collaboration. Our leadership team is passionate about the work we do and the benefits we deliver to clients, and that commitment is demonstrated on a daily basis through strategic vision, open door policies, and a high level of interaction with team members across the company. From improved PTO policies, to mentorship, to elective volunteerism and even healthy snacks and a workout facility at headquarters, we are making this a place people want to be."

AGC Biologics Wins CDMO Leadership Awards

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the company won two awards from the annual CDMO Leadership awards, sponsored by Outsourced Pharma and Life Science Connect. AGC Biologics was named a winner in both the “Biologics – Global” and “Cell & Gene – Global” categories and is one of the few in the industry that scored high enough to be honored in multiple categories. The awards are decided through survey-based scoring and focus on a set of performance metrics across important areas such as facilities, innovation, scientific expertise, on-time delivery, seamless delivery across phases, manufacturing capabilities, and quality management systems. The program independently surveys leading global biopharma and biotechnology organizations to tabulate scores and uses feedback from only experienced industry leaders to decide the best CDMOs in the world. “We are honored that our customers and industry leaders have confidence in our global CDMO services for biologics and cell and gene therapies,” said Alberto Santagostino, CEO and President, AGC Biologics. “AGC Biologics remains committed to offering friendly and expert CDMO services and being a collaborative partner. This is what we stand for. We aim to be a safe harbor for our Biopharma companies to help bring life-changing treatments to patients around the globe.” “We are thrilled to introduce our 2025 CDMO Leadership Awards winners to the Outsourcing community, and honored to offer such an important tool for drug sponsors in selecting their best-fit partner to help bring life-saving therapies to market,” says Outsourced Pharma Chief Editor Louis Garguilo. “The new categories and enhanced scoring methodology that went into this year’s appraisal bring an improved experience for drug sponsors using the resource as well as an ever-so-coveted distinction for the CDMOs. The unveiling of the award champions during our celebration in March will be an exciting new addition to the festivities.”